[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Bhavneesh Sharma MBBS, MD, MBA (Finance) @bs2537 on x 7877 followers
Created: 2025-07-21 18:30:35 UTC
Long Cytokinetics, $CYTK. My analysis points to a $XX PT (+36% upside)-1 year timeframe.
Thesis: Aficamten PDUFA: Dec 26, 2025. High probability of approval for oHCM. Superior Profile: Better efficacy & safety vs. $BMY's Camzyos. TAM Expansion: ACACIA trial in nHCM could unlock a ~$2B+ market. Funded: Cash runway through commercialization. #Biotech #Investing #Cardiology #PDUFA
XXXXX engagements
Related Topics investment $2b $bmys superior finance sharma $cytk